Home  /  Resource Library  /  Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure

Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure

Study investigated tafasitamab with lenalidomide for treatment of DLBCL.